Selected research publications
Modified recombinant human IgG1‐Fc is superior to natural IVIG at inhibiting immune‐mediated demyelination – Journal: Immunology – Published: 1st September 2021
The therapeutic potential of sialylated fragment crystallizable (Fc) domains of human IgG – Journal: mAbs – Published: 21st July 2021
Animal derived antibodies should be considered alongside convalescent human plasma to deliver treatments for COVID-19 – Journal: Wellcome Open Research – Published: 2nd June 2020
Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses – Journal: Journal of Immunology – Published: 15th February 2020
Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers to Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus – Journal: Journal of Immunology – Published: 1st March 2019
View more publications